BlackRock, Inc. Amendment to Schedule 13G/A for Inspire Medical Systems Inc.

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for Inspire Medical Systems Inc., reporting a decrease in its ownership. As of September 30, 2025, BlackRock, Inc. beneficially owns 3,353,407 shares of Inspire Medical Systems Inc.'s common stock, representing 11.3% of the total outstanding shares. This marks a decrease of 5,009,339 shares, or 59.9%, from its previous filing. The filing indicates that BlackRock, Inc. holds these shares in the ordinary course of business and not for the purpose of influencing the control of the issuer. The amendment also includes a certification that the securities were not acquired for the purpose of changing or influencing the control of the issuer. The filing was signed by Spencer Fleming, Managing Director of BlackRock, Inc.